Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

The prevalence of hepatitis C virus (HCV) infection in Asian countries is high. This study assessed the efficacy and safety of elbasvir/grazoprevir (EBR/GZR) in participants with HCV infection from Asia‐Pacific countries and Russia. In this phase 3, randomized, placebo‐controlled, double‐blind study...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Jacob, Burnevich, Eduard, Sheen, I‐Shyan, Heo, Jeong, Kinh, Nguyen Van, Tanwandee, Tawesak, Cheng, Pin‐Nan, Kim, Do Young, Tak, Won Young, Kizhlo, Svetlana, Zhdanov, Konstantin, Isakov, Vasily, Liang, Liwen, Lindore, Pauline, Ginanni, Joy, Nguyen, Bach‐Yen, Wahl, Janice, Barr, Eliav, Robertson, Michael, Ingravallo, Paul, Talwani, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944586/
https://www.ncbi.nlm.nih.gov/pubmed/29761174
http://dx.doi.org/10.1002/hep4.1177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944586/
https://www.ncbi.nlm.nih.gov/pubmed/29761174
http://dx.doi.org/10.1002/hep4.1177

Ejemplares similares